CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
T-lymphoblastic lymphoma (T-LBL) is a rare hematological malignancy with highly aggressive, unique clinical manifestations, and poor prognosis. Cell division cycle 27 (CDC27) was previously reported to be a significant subunit of the anaphase-promoting complex/cyclosome. However, the specific functi...
Main Authors: | Yue Song, Wei Song, Zhaoming Li, Wenting Song, Yibo Wen, Jiwei Li, Qingxin Xia, Mingzhi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00488/full |
Similar Items
-
Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
by: Hongwen Li, et al.
Published: (2022-10-01) -
Emerging roles of the gut microbiota in cancer immunotherapy
by: Zhuangzhuang Shi, et al.
Published: (2023-02-01) -
T-cell dysfunction in natural killer/T-cell lymphoma
by: Xiaoyan Feng, et al.
Published: (2023-12-01) -
PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma
by: Jiazhuo Wu, et al.
Published: (2023-07-01) -
Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
by: Awais Arshed, et al.
Published: (2022-11-01)